Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2019-01-14
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$93.79-4,000469,791-1%-$375,160
2019-01-14
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.03+45,00020,646,1230%+$1,487
M
2019-01-11
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$10.53-8,0193,024,8720%-$84,472
M
2019-01-09
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.02+21,00026,689,8970%+$498
D
2019-01-11
DCPHDeciphera Pharmaceuticals, Inc.Flynn Daniel LeeChief Scientific OfficerS - Sale+OE$26.00-300147,0490%-$7,800
DM
2019-01-14
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$114.85-14,108683,795-2%-$1,620,256
2019-01-11
XERSXeris Pharmaceuticals IncPrestrelski StevenChief Scientific OfficerS - Sale$0.00-2,300487,0240%-$0
D
2019-01-14
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale+OE$186.71-2,12539,609-5%-$396,759
2019-01-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.74+15,000212,304,6330%+$56,055
D
2019-01-10
CCXIChemocentryx, Inc.Schall Thomas J.Pres, CEOS - Sale+OE$12.16-36,7622,228,855-2%-$447,092
D
2019-01-10
CCXIChemocentryx, Inc.Cappel Markus J.Chief Bus. Officer, TreasurerS - Sale+OE$12.00-6,17235,441-15%-$74,079
D
2019-01-10
BHVNBiohaven Pharmaceutical Holding Co Ltd.Tilton JohnChief Commercial OfficerS - Sale+OE$37.67-10,5001,614-87%-$395,535
2019-01-10
INSMInsmed IncAltomari AlfredDirS - Sale$22.50-5,50042,442-11%-$123,750
AM
2015-06-15
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.00+20,601,12339,827,780+107%+$852
M
2016-06-20
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianCEOP - Purchase$0.00+1,045,00020,271,657+5%+$852
2019-01-10
AMARAmarillo Biosciences IncChen Stephen TPres, COB, CEO, 10%P - Purchase$0.27+1,0006,600,3600%+$270
2019-01-10
SCYXScynexis IncTaglietti MarcoCEOP - Purchase$0.69+25,000480,000+5%+$17,250
D
2019-01-11
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$113.59-7,054683,795-1%-$801,235
2019-01-11
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.83+10,000212,289,6330%+$38,325
2019-01-08
STMLStemline Therapeutics IncHoberman KennethCOOS - Sale$10.15-13,547646,652-2%-$137,502
D
2019-01-10
AMRNAmarin Corp PlcukZakrzewski Joseph SDirS - Sale+OE$16.98-200,00084,547-70%-$3,396,390
2019-01-07
MYOKMyokardia IncGianakakos AnastasiosPres, CEOS - Sale$44.11-2,770702,0400%-$122,197
D
2019-01-10
AMRNAmarin Corp PlcukStack David MDirS - Sale+OE$18.00-125,5040-100%-$2,259,072
D
2019-01-11
AMRNAmarin Corp PlcukKennedy Joseph TGCS - Sale+OE$18.92-3,173217,934-1%-$60,033
D
2019-01-09
AMRNAmarin Corp PlcukKalb Michael WayneSVP, CFOS - Sale+OE$15.26-200,00017,486-92%-$3,051,080
D
2019-01-10
AMRNAmarin Corp PlcukEkman LarsDirS - Sale+OE$17.28-140,4160-100%-$2,426,489
2019-01-09
FTSVForty Seven, Inc.Weissman IrvingDirS - Sale$17.05-10,0002,132,7610%-$170,490
2018-12-26
FTSVForty Seven, Inc.Weissman IrvingDirS - Sale$15.77-10,0002,142,7610%-$157,685
2019-01-10
CYTKCytokinetics IncMalik Fady IbrahamEVP Research, DevelopmentS - Sale$7.31-1,50085,567-2%-$10,965
2019-01-11
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$10.87-36,311413,632-8%-$394,810
2019-01-11
SPPISpectrum Pharmaceuticals IncGustafson Kurt AEVP, CFOS - Sale$10.87-33,692227,056-13%-$366,333
2019-01-11
ARWRArrowhead Pharmaceuticals, Inc.Waddill William D.DirS - Sale$14.77-8,50046,500-15%-$125,545
M
2019-01-09
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$3.88+13,99618,169,7990%+$54,335
D
2019-01-10
ENOBEnochian Biosciences IncGronfeldt-Sorensen HenrikDirP - Purchase$2.00+50,00050,000New+$100,000
D
2019-01-09
ACADAcadia Pharmaceuticals IncBrege LauraDirS - Sale+OE$20.00-10,0000-100%-$200,041
D
2019-01-10
ZGNXZogenix, Inc.Farr Stephen JPres, CEOS - Sale+OE$45.00-90,31351,947-63%-$4,064,085
D
2019-01-10
REGNRegeneron Pharmaceuticals IncGoldstein Joseph LDirS - Sale+OE$410.00-1,79112,323-13%-$734,310
D
2019-01-10
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$90.55-3,000469,791-1%-$271,650
2019-01-10
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.69+10,000212,279,6330%+$36,908
DM
2019-01-08
PAHCPhibro Animal Health CorpBendheim Daniel MEVP, Corporate StrategyS - Sale+OE$32.42-5,0000-100%-$162,125
M
2019-01-08
ARPOAerpio Pharmaceuticals, Inc.Satter Muneer ADir, 10%P - Purchase$2.35+63,8185,621,835+1%+$150,290
D
2019-01-08
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$91.59-6,000469,791-1%-$549,523
2018-12-17
KURAKura Oncology, Inc.Ecor1 Capital Fund Qualified, L.P.10%S - Sale$13.20-26,5204,408,097-1%-$350,064
M
2018-12-18
KURAKura Oncology, Inc.Ecor1 Capital Fund Qualified, L.P.10%P - Purchase$13.57+213,8884,408,097+5%+$2,901,833
2019-01-08
AMARAmarillo Biosciences IncChen Stephen TPres, COB, CEO, 10%P - Purchase$0.27+4,0006,599,3600%+$1,070
M
2019-01-08
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$10.87-15,8023,032,891-1%-$171,827
2019-01-08
TTPHTetraphase Pharmaceuticals IncDumas JacquesChief ScientificOfficerS - Sale$1.60-7,4970-100%-$11,995
DM
2019-01-09
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$113.51-14,108683,795-2%-$1,601,356
2019-01-09
FLKSFlex Pharma, Inc.Boston Foundation, Inc.10%S - Sale$0.37-337,0001,600,000-17%-$123,848
2019-01-09
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.65+10,000212,269,6330%+$36,501
M
2019-01-07
MRTXMirati Therapeutics, Inc.Davis Aaron I.Dir, 10%S - Sale$47.68-50,0002,116,242-2%-$2,383,803
DM
2019-01-08
MRTXMirati Therapeutics, Inc.Boxer Capital, LLC10%S - Sale+OE$51.98-700,0001,565,560-31%-$36,389,172
DM
2019-01-07
CCXIChemocentryx, Inc.Schall Thomas J.Pres, CEOS - Sale+OE$12.02-20,1702,228,855-1%-$242,370
2019-01-07
AMARAmarillo Biosciences IncChen Stephen TPres, COB, CEO, 10%P - Purchase$0.27+3,0006,595,3600%+$810
2019-01-07
ICPTIntercept Pharmaceuticals, Inc.Bright LisaPres, InternationalS - Sale$104.93-1,31318,807-7%-$137,773
DM
2019-01-07
CCXIChemocentryx, Inc.Cappel Markus J.Chief Bus. Officer, TreasurerS - Sale+OE$12.03-13,20335,441-27%-$158,790
M
2019-01-08
RTRXRetrophin, Inc.Reed Elizabeth ESVP, GC, Corporate SecretaryS - Sale$23.95-1,50016,327-8%-$35,933
D
2019-01-07
FGENFibrogen IncSchoeneck James ADirS - Sale+OE$45.90-2,00027,700-7%-$91,800
2019-01-07
PTCTPtc Therapeutics, Inc.Almstead Neil GregoryChief Technical Ops OfficerS - Sale$34.75-65323,045-3%-$22,692
2019-01-07
PTCTPtc Therapeutics, Inc.Souza MarcioCOOS - Sale$34.75-832,742-3%-$2,884
2019-01-07
PTCTPtc Therapeutics, Inc.Utter Christine MariePrincipal Financial OfficerS - Sale$34.75-2977,446-4%-$10,321
D
2019-01-07
PTCTPtc Therapeutics, Inc.Peltz Stuart WalterCEOS - Sale+OE$34.75-2,51242,420-6%-$87,292
D
2019-01-07
DCPHDeciphera Pharmaceuticals, Inc.Kelly Thomas PatrickCFOS - Sale+OE$25.18-5,0000-100%-$125,900
D
2019-01-07
RETAReata Pharmaceuticals IncWilson Jason DouglasCFOS - Sale+OE$72.04-20,0000-100%-$1,440,820
D
2019-01-07
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale+OE$10.23-12,5001,320,271-1%-$127,824
D
2019-01-07
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale+OE$10.23-12,5001,320,271-1%-$127,824
M
2019-01-03
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPresP - Purchase$0.02+8,20026,668,8970%+$154
D
2019-01-07
BMRNBiomarin Pharmaceutical IncBienaime Jean JacquesCEOS - Sale+OE$87.58-3,000469,791-1%-$262,740
2019-01-08
FLKSFlex Pharma, Inc.Boston Foundation, Inc.10%S - Sale$0.40-263,0001,937,000-12%-$104,306
DM
2019-01-07
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$113.28-14,109683,795-2%-$1,598,276
2019-01-08
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.61+35,000212,259,6330%+$126,376
DM
2019-01-04
ITCIIntra-Cellular Therapies, Inc.Mates SharonCOB, Pres, CEOS - Sale+OE$11.58-52,2021,138,707-4%-$604,310
DM
2019-01-04
ITCIIntra-Cellular Therapies, Inc.Halstead MichaelEVP, GCS - Sale+OE$11.58-24,566191-99%-$284,418
DM
2019-01-04
ITCIIntra-Cellular Therapies, Inc.Hineline Lawrence J.SVP of Finance CFOS - Sale+OE$11.58-24,56615,832-61%-$284,383
DM
2019-01-04
ITCIIntra-Cellular Therapies, Inc.Vanover Kimberly E.SVP, Early Stage Clinical Dev.S - Sale+OE$11.52-10,15627,068-27%-$116,979
D
2019-01-04
ITCIIntra-Cellular Therapies, Inc.Davis Robert ESVP, Chief Scientific OfficerS - Sale+OE$11.46-9,56443,989-18%-$109,630
DM
2019-01-07
ARNAArena Pharmaceuticals IncKlassen PrestonEVP, CMOS - Sale+OE$42.06-19,0000-100%-$799,066
D
2019-01-04
FTSVForty Seven, Inc.Takimoto Chris HChief Medical OfficerS - Sale+OE$15.55-8,0000-100%-$124,362
2019-01-04
MYOKMyokardia IncGianakakos AnastasiosPres, CEOP - Purchase$39.86+2,500704,8100%+$99,647
D
2019-01-07
SPPISpectrum Pharmaceuticals IncMaida Anthony E IIIDirS - Sale+OE$10.00-7,25032,988-18%-$72,500
M
2019-01-04
CERCCerecor Inc.Armistice Capital, LLCDir, 10%P - Purchase$3.48+27,00418,155,8030%+$93,914
2019-01-07
TCDATricida, Inc.Otto Dawn ParsellSVP, Clinical DevelopmentS - Sale$23.27-6650-100%-$15,475
2019-01-07
IMGNImmunogen IncGregory Richard J.EVP, CSOS - Sale$5.27-3,038236,056-1%-$16,014
2019-01-07
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$3.56+55,000212,224,6330%+$195,922
M
2019-01-03
ARPOAerpio Pharmaceuticals, Inc.Satter Muneer ADir, 10%P - Purchase$2.12+60,0005,558,017+1%+$127,462
2019-01-07
VRCAVerrica Pharmaceuticals Inc.Stalfort SeanDirP - Purchase$10.45+9,221430,860+2%+$96,386
2019-01-07
VRCAVerrica Pharmaceuticals Inc.Manning Paul BDir, 10%P - Purchase$11.18+47,5009,622,3610%+$530,811
D
2019-01-07
IMDZImmune Design Corp.Paya Carlos VPres, CEOS - Sale+OE$1.58-13,014156,576-8%-$20,591
D
2019-01-07
OPHTOphthotech Corp.Westby KeithSVP, COOS - Sale+OE$1.30-29932,606-1%-$389
D
2019-01-07
IMDZImmune Design Corp.Ter Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$1.59-3,41483,982-4%-$5,415
D
2019-01-07
OPHTOphthotech Corp.Guyer David RExec COBS - Sale+OE$1.30-3,85943,164-8%-$5,017
D
2019-01-07
IMDZImmune Design Corp.Yurasov SergeySVP, Clinic. Devel., CMOS - Sale+OE$1.57-3,52278,756-4%-$5,536
D
2019-01-07
IMDZImmune Design Corp.Brady Stephen REVP, Strategy, FinanceS - Sale+OE$1.58-5,51696,599-5%-$8,722
DM
2019-01-03
PAHCPhibro Animal Health CorpBendheim Daniel MEVP, Corporate StrategyS - Sale+OE$31.74-7,5000-100%-$238,075
DM
2019-01-03
FGENFibrogen IncNeff Thomas BCEOS - Sale+OE$44.39-60,0005,420,890-1%-$2,663,480
M
2018-05-02
AZRXAzurrx Biopharma, Inc.Ross Edmund Burke Jr.10%P - Purchase$1.35+139,5452,540,555+6%+$188,472
D
2019-01-04
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$111.51-7,055683,795-1%-$786,719
M
2019-01-03
VRCAVerrica Pharmaceuticals Inc.Davidson Matt10%S - Sale$9.80-33,2763,048,693-1%-$326,259
M
2019-01-03
KALVKalvista Pharmaceuticals, Inc.Svlsf Iv, LLC10%S - Sale$20.25-4,29970,222-6%-$87,073
2019-01-04
ESPREsperion Therapeutics, Inc.Biotech Target N V10%P - Purchase$41.29+80,0003,472,964+2%+$3,303,256
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top